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Abstract: The Vip3 proteins produced during vegetative growth by strains of the bacterium
Bacillus thuringiensis show insecticidal activity against lepidopteran insects with a mechanism of
action that may involve pore formation and apoptosis. These proteins are promising supplements
to our arsenal of insecticidal proteins, but the molecular details of their activity are not understood.
As a first step in the structural characterisation of these proteins, we have analysed their secondary
structure and resolved the surface topology of a tetrameric complex of the Vip3Ag4 protein by
transmission electron microscopy. Sites sensitive to proteolysis by trypsin are identified and the
trypsin-cleaved protein appears to retain a similar structure as an octomeric complex comprising four
copies each of the ~65 kDa and ~21 kDa products of proteolysis. This processed form of the toxin
may represent the active toxin. The quality and monodispersity of the protein produced in this study
make Vip3Ag4 a candidate for more detailed structural analysis using cryo-electron microscopy.
Keywords: Vip3 toxin; electron microscopy; surface topology
1. Introduction
Bacillus thuringiensis (Bt) is a Gram-positive entomopathogenic bacterium with strains that show
toxicity to a wide variety of invertebrates [1]. The best-studied toxins produced by these strains are the
crystal (Cry) and cytolytic (Cyt) toxins, also known as δ-endotoxins, which are synthesized during
the stationary growth phase and into sporulation as parasporal crystalline inclusions [2]. In addition,
Bt synthesizes other insecticidal proteins that are secreted to the culture medium during the vegetative
growth phase: vegetative insecticidal proteins (Vip) [3,4] and secreted insecticidal proteins (Sip) [5].
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Vip proteins have been classified into four families; Vip1, Vip2, Vip3 and Vip4, according to their degree
of amino acid similarity [6]. Vip1 and Vip2 act together as a binary toxin with insecticidal activity
against some coleopteran [4] and hemipteran pests [7] and function through the ADP-ribosyltransferase
activity of Vip2 [8], the structure of which has been solved [9]. The Vip4 protein is distantly related to
the Vip1 component of this binary toxin, but its activity remains unknown to date [10].
Vip3 proteins have no primary sequence homology to the other Vip proteins or other toxins
and exhibit toxicity against lepidopteran larvae [3,11]. As for the Cry and Cyt toxins of Bt, the Vip3
proteins are named according to the degree of amino acid identity between family members with
subdivisions of the protein family having different secondary rank (denoted by the capital letter)
at <78% identity, tertiary rank (denoted by the lower case letter) at <95%, and a quaternary rank
(denoted by the final number) assigned to each new entry into the nomenclature [6]. Vip3Aa proteins
appear to recognise distinct receptors from Cry1 toxins in Manduca sexta [12], Agrotis segetum [13] and
Spodoptera littoralis [14], which is consistent with reports that insects resistant to Cry toxins are not
cross-resistant to Vip3 proteins [12,15,16]. This has made Vip3 proteins attractive as additional insect
resistance traits in transgenic crops (e.g., [17,18]).
The current understanding of the mode of action of Vip3 proteins remains limited, although
a number of steps towards intoxication are known [19]. Proteolysis of the ~88 kDa full-length Vip3A
proteins to ~65 kDa by trypsin or the gut juices of both susceptible and non-susceptible insects has
been reported [12,13,20,21]. It has been proposed that differences in the amounts of further digestion
products accumulated may be linked to levels of susceptibility to the toxins [20,21]. Binding of
proteolytically processed Vip3A proteins to ligands of 55 and 100 kDa in Ephestia kuehniella [14],
80 and 100 kDa in Manduca sexta [12] or of 65 kDa in Agrotis segetum [13] has been reported and using a
two-hybrid system, a putative ~43 kDa receptor with homology with the tenacins has been identified
in Agrotis ipsilon [22]. Toxin activated by gut juices is able to form pores in planar lipid bilayers
and dissected Manduca sexta gut tissue [12]. The histopathology of intoxication shows cytoplasmic
vacuolization and breakup of the brush border membrane [13,14] and there is evidence that Vip3Aa
causes apoptosis in Spodoptera frugiperda Sf9 cells [22,23]. However, an understanding of the molecular
mechanism of the Vip3 proteins is hampered by the absence of structural data. As a first stage in
the process of 3D-structure determination, here we describe the expression, purification and analysis
of the trypsin processing of the Vip3Ag4 protein. We analyse its secondary structure and present
approximately 33 Å resolution surface topologies of both a Vip3Ag4 tetramer and a trypsin-processed
complex, determined via transmission electron microscopy and single particle analysis.
2. Results and Discussion
2.1. Purification of Vip3Ag4
Expression of Vip3Ag4 in Escherichia coli and purification by nickel affinity chromatography
resulted in a single band of around 91 kDa on SDS PAGE, consistent with the expected size for the
recombinant protein including His-tag (91.38 kDa). Size exclusion chromatography produced several
peaks (Figure 1). The first, small peak emerging at 40 min may represent aggregated material, the largest
peak (60 min) has an approximate molecular mass (calculated with respect to gel filtration standards)
of 354 kDa, which corresponds approximately to a tetrameric form. There is a further shoulder to this
peak (~70 min) that appears to represent monomeric Vip3Ag4. A recent study with Vip3Aa35 (82%
identical to Vip3Ag4), activated with trypsin, indicated the presence of aggregated, monomeric and
tetrameric forms of this protein; the proportions of these forms could be manipulated by changing
buffer conditions [24]. Fractions corresponding to the putative tetrameric form of Vip3Ag4, chosen to
exclude those that might include the monomeric form were combined and the protein was concentrated
to 1 mg/mL. Mass spectrometric analysis of this material revealed a protein of 91,245.5 Da, a size that
demonstrates the production of the monomeric, His-tagged protein, lacking the initial Met residue
(theoretical mass 91,245.7). Initiator methionine residues are often removed by E. coli methionine
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aminopeptidases, especially when, as in the recombinant Vip3Ag4, the next residue has a small
sidechain (in this case glycine) [25].
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Figure 1. Size exclusion chromatography analysis of the initial Vip3Ag4 preparation. The absorption
of the Vip3Ag4 at 280 nm over time is shown. The major peak, emerging around 60 min, corresponds
to the Vip3 tetramer.
2.2. Trypsin Processin
Trypsin digestion of the Vip3Ag4 protein produced bands of ~65 kDa and ~21 kDa on SDS PAGE.
The larger band was subjected to five cycles of N-terminal sequencing and revealed the sequence
N/K-S-S-E/P-A, which is consistent with the sequence NSSPA that starts at residue N199 of the native
Vip3Ag4 s quence (residue 233 of th His-tagged r combinant protein). Mass spectrometry of t
products of trypsin digestion revealed two major peaks with molecular weights of 65,401.0 and 20,740.0.
These masses match the region of Vip3Ag4 from N199 to the C—terminal residue (exp cted m ss
65,401.2) and the r gion from D33 of the His tagged recombinant protein (two residu s upstream of
the initiator Met of the naturally-occurring protein) to K182 of the native Vip3Ag4 sequence (residue
216 of th recombinant protein—expected mass 20,740.7). Cleavage sites ar shown on the primary
sequence of the recombinant Vip3Ag4 in Figure S1. The tr psin processing i dicated by these peaks
would also produce a further fragment from F183 to K198 (FEDLTFATETTLKVKK) and th N-terminal
region of the recombinant prot in, but peaks correspondi g to these fragments were not observed.
The pattern of digestion seen with Vip3Ag4 is consistent with other r ports of Vip3 processing by both
trypsin and insect gut extr cts [12,13,20,21]. Estruch et al. [22] r ported a similar initial processing of
Vip3Aa by gut juices from A. ipsilon to fragments of ~22 kD (residues 1–198) and ~65 kDa (residue
200–789), althoug they did not see proces ing after the conserved K182 residu . Gut juice was then
seen to cause further proteoly is of the ~65 kDa Vip3Aa fragment to ~45 kDa (residues 412–789) or
~33 kDa (residues 200–455). These further degradation products were not seen in the present study
with Vip3Ag4. This may be due to sequenc differen s in the two toxins: Vip3Ag4 has the sequence
KTK (residues 455–457) in place f the Vip3Aa sequence KKK, which may affect trypsin-like cleavag
in t is region to ge erate the ~33 kDa product. T resence of proteolytic activities other than trypsin
in th gut juic is also likely given the cleavage between Thr411 and Asn412 that generates the ~45 kDa
product [22], since this site is conserved in Vip3Ag4.
When the trypsin-treated Vip3Ag was analysed by Size exclusio chromatography (SEC), th re
was no signific nt change in t e elution time for t e major p ak compared to unprocessed material
(Figure 2a) and when fractions from this peak were analysed by SDS PAGE, both ~21 and ~65 kDa
bands were seen (Figure 2b). This indicates not only that the ~21 kDa trypsin-cleaved fragment
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from D33-K216 of the recombinant protein remains associated with the larger ~65 kDa fragment after
digestion, but also that the processed Vip3Ag toxin remains in the multimeric complex form in solution.
Kunthic et al. recently described a variety of monomeric and oligomeric forms of trypsin-treated
Vip3Aa35 including a form arising after the addition and dialysis of detergent that appeared to be
a tetramer of the ~66 kDa polypeptide only. Our experiments suggest that, in the absence of detergent
treatment, Vip3Ag4 treated with trypsin is an octameric complex consisting of tetramers of both the
~65 kDa and 21 kDa fragments. This is consistent with the finding that the trypsin cleavage products of
Vip3Aa16 (82% identical to Vip3Ag4) remain associated [26] and may indicate that the proteolytically
cleaved complex is the active form of the toxin. The sensitivity of S. exigua larvae to Vip35Aa in
full-length or trypsin-processed forms shows no significant difference [24]. Since trypsin-like cleavage
of the full-length form would be expected in vivo in the insect gut, these results show that trypsin
cleavage does not reduce activity and the processed form may be the active agent. The stability of
the 65 kDa product of Vip3Aa shows a correlation to differences in species susceptibility [20] and gut
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was  performed. Analysis  of  the  data  using  the Dichroweb  server  found  the  best  fit  of  data  to 
reference datasets using the CONTIN analysis program and reference set 3 [27]. Using these tools, a 







Figure 2. Analysis of purified Vip3Ag4 before and after trypsin treatment. (a) SEC of unprocessed and
trypsin-treated recombinant Vip3Ag4; (b) SDS Poly Acrylamide Gel Electrophoresis of unprocessed
Vip3Ag4 (U) and the SEC peak from try sin-treated Vip3Ag4 (P); the sizes of protein markers (M)
are indicated.
2.3. Circular Dichroism
To estimate the secondary structure content of the Vip3Ag4 protein, circular dichroism analysis
was performed. Analysis of the data using the Dichroweb server found the best fit of data o reference
datasets using the CONTIN analysis progr m and reference set 3 [27]. Using these tools, a good match
with reference data was obtained for most of th curve (Figure S2), suggesting a s condary structure
conte t in the tetrameric Vip3Ag4 of ~11% alpha helix, ~38% ß sheet, 22% loops and 30% unordered.
2.4. SEC-MALLS
In order to achieve an accurate reconstruction of TEM data to produce a structure, it is essential
to know the multimeric form of the protein being analysed. To verify our initial observations during
purification, we undertook SEC-MALLS and analytical ultracentrifugation analyses.
The elution profile of the Vip3Ag4 sample contained a single peak (Figure 3). The molecular mass
obtained from the SEC-MALLS analysis was consistent with that of a Vip3Ag4 tetramer (Table S1).
It was noted that the molecular mass across the peak appeared to increase from the leading- to the
trailing-edge of the peak, which is suggestive of non-ideal behaviour.
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Figure  4.  Sedimentation  coefficient  distribution  for  Vip3Ag4  at  varying  concentrations.   
(a)  Interference data. Blue 1.0 mg/mL, red 0.5 mg/mL and cyan 0.25 mg/mL;  (b) Absorbance data. 
Purple 0.5 mg/mL and yellow 0.25 mg/mL. 
Figure 3. SE - l i f t oli i t t f ip3 . LS—light scattering;
dRI—differ ntial refractive index; UV—UV at 280 n ; i t.
2.5. Analytical Ultracentrifugation
Analysis of Vip3Ag4 by sedimentation velocity (SV) also suggests that the protein is tetrameric
(Table S2). During analysis of the interference data, corrections were made for buffer sedimentation,
without which the molecular masses obtained were inconsistent with those obtained from analysis of
the absorbance data and from the SEC-MALLS analysis. A decrease in sedimentation coefficient with
increasing concentration was noted, suggestive of non-ideal sedimentation (Figure 4). An attempt to
determine the concentration-dependent coefficient, ks, by linear extrapolation of a plot of 1/S(20,w)
against concentration yielded very high values, suggesting that other factors apart from excluded








Figure  3.  SEC‐MALLS  analysis  of  the  oligomeric  state  of  Vip3Ag4.  LS—light  scattering;   
dRI—differential refractive i dex; UV—UV at 280 nm; MW—m lecular weight. 
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Figure  4.  Sedimentation  coefficient  i t i ti   f   ip3Ag4  at  varying  concentrations.   
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Figure 4. Sedimentation coefficient distribution for Vip3Ag4 at varying concentrations. (a) Interference
data. Blue 1.0 mg/mL, red 0.5 mg/mL and cyan 0.25 mg/mL; (b) Absorbance data. Purple 0.5 mg/mL
and yellow 0.25 mg/mL.
2.6. Surface Structure of Vip3Ag
From 100 TEM images of grids incubated with Vip3Ag4, 3492 single particles were picked. Many of
these appeared visually to show four-fold symmetry, consistent with our SEC-MALLS and analytical
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ultracentrifugation (AUC) data (Figure 5). From these particles, EMAN 2 was used to generate a collection
of 70 2D class averages (example subset shown in Figure 6a). These were used in the subsequent
construction of a modelled surface of the Vip3Ag4 protein (Figure 7a), based on four-fold symmetry
as indicated from our SEC-MALLS and SV data. An excellent correlation was observed between 2D
class averages and reprojections from the final structure (Figure 6a,b). Fourier shell correlation (FSC)
analysis in EMAN2 of structures derived from odd- and even-numbered particles indicated a resolution
of approximately 33 Å (FSC = 0.5 criterion: Figure S3). The structure, displayed at a volume threshold
consistent with a protein particle of approximately 380 kDa (Figure 7a), shows four clear lobes. When the
analysis was repeated in the presence of Ni-NTA-nanogold particles, particle sets that were similar to
the original protein were produced (Figure S4a). Reconstruction from the TEM images obtained, based
on the initial structure, again gave good correlations between these class averages and the reprojections
from the final structure (Figure S4b). Gold particles are clearly visible between the lobes of the tetramer
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Figure 7. Surface topol gy of Vip3Ag4. Structures, with (a) nd without (b) nanogold are displayed at
volume shells corresponding to the expected molecular mass of Vip3 tetramers (380 kDa). The structure
of the protein in the prese ce of gold is shown in green while the gold is s own in orange. Topology
displayed using UCSF Chimera [28].
Analysis of the surface topology of the trypsin-treated Vip3Ag4 again showed good correlation
between TEM class averages and reprojections fro the odel (Figure S5). This structure sho s
a s all region of disconnected density that is likely to be an artifact that may be caused by a bias in the
views of the protein on the grid that were used to generate the model. The overall structure shows
little change relative to the unprocessed protein (Figure S6) within the resolution of the models. This is
consistent with the data above showing that the structure of the complex is maintained with little
change following trypsin treatment.
3. Conclusions
These results illustrate for the first time structural data on a me ber of the Vip3 rotein family, at
the level of surface topology. Our data in icate that the predominant molecular species of Vip3Ag4
is a tetramer, and that the tetrameric form and general topology are retained after trypsin tr a ment.
Trypsinised Vip3A is able to form pores in artificial bil yers and n M. sexta gut cells [12], and pore
forming toxins frequently requir multimer sation befo e or during membrane insertion. Wheth r he
tetrameric form of Vip3Ag4 seen here form a structural precursor to pore formation remains to be
established. In addit on to providing initial structural nsight into the Vip3Ag4 protein, this work
establishes that the Vip3Ag4 purity and monodispersity, i addition to the actual size of the etrameric
form, m ke this protein a candidate for full struc ural analysis using the emerging technique of
cryo-electron microscopy.
4. Materials and Methods
4.1. E. coli Expression and Purification of Vip3Ag4 Protein
The Vip3Ag4 protein was first identified in a Spanish collection of Bt strains and cloned for
recombinant expression [29]. Recombinant E. coli BL21(DE3) strain harbouring the vip3Ag4 gene in the
pET28b vector was pre-cultured overnight in an orbital shaker at 37 ◦C and 200 rpm in 2× YT medium
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supplemented with 50 µg/mL kanamycin. A 1/25 dilution of this pre-culture into 500 mL 2× YT
medium containing 50 µg/mL kanamycin was further incubated for 8 h at 37 ◦C with vigorous agitation
(250 rpm). Protein expression was induced by adding isopropyl-beta-D-1-thiogalactopyranoside to
a final concentration of 1 mM and incubation for up to 16 h. Samples were centrifuged at 5000 g
for 15 min at 4 ◦C, and the resulting pellet was weighed and resuspended with 3 mL per gram
of sonication buffer (20 mM sodium phosphate buffer pH 7.4, 0.5 M NaCl, 3 mg/mL lysozyme
(Sigma-Aldrich, Gillingham, United Kingdom), 25 U Benzonase (Novagen, Madison, Wis, USA) and
100 µM phenyl-methylsulfonyl fluoride). Samples were further incubated at 37 ◦C under gentle
agitation for 1 h and were sonicated on ice with a Branson analog sonifier 250 (Branson Ultrasonics
Corporation, Danbury, CT, USA) by applying two 1 min pulses with a constant duty cycle at 60 W,
separated by a 1 min cooling period. Insoluble material was pelleted at 12,000 g for 30 min at 4 ◦C
and the soluble fraction was sequentially filtered through sterile 0.45 and 0.22 µm syringe filters.
Protein purification was performed at room temperature (RT) using Protino Ni-TED 2000 Packed
Columns following the manufacturer’s instructions (Macherey–Nagel, Düren, Germany). After the
polyhistidine-tagged protein was eluted, a buffer exchange procedure was performed immediately
with Milli-Q water and GE Healthcare PD-10 desalting columns to reduce protein aggregation and
precipitation [29]. Subsequently, 5 mL samples were applied to a Hi-Prep 16/60 Sephacryl S-300 size
exclusion column equilibrated with 20 mM TrisHCl, pH 8.0, 300 mM NaCl using an AKTA Prime
Plus (GE Healthcare, Little Chalfont, UK) at a flow rate of 0.5 mL/min. The same column was also
calibrated with gel filtration standards (BioRad, Watford, UK). Fractions (10 mL) were collected and
the protein concentration was quantified by the Bradford method [30].
4.2. Trypsin Treatment of Vip3Ag4
Vip3Ag4 was diluted to 0.4 mg/mL in PBS and 200 µL was incubated with 8 µL of 0.1 mg/mL
trypsin (a 100:1 w:w ratio) at 37 ◦C for 2 h. The products of the incubation were separated by SDS
PAGE (12% acrylamide) with a tricine running buffer. Bands were blotted onto PVDF membrane
and revealed by rapid staining with Coomassie blue R-250 and subjected to N-terminal sequencing
(Abingdon Health Laboratory Services, Birmingham, UK). A sample from the same digestion was
also analysed by mass spectrometry (Waters, Elstree, UK, Tri-wave IMS system with integrated high
resolution MS capability).
4.3. Mass Spectrometry
Mass spectrometry was carried out using a Waters, Elstree, UK, Synapt G2-Si time of flight mass
spectrometer coupled to a Waters Acquity UPLC equipped with a UPLC C4 column held at 60 ◦C.
4.4. Circular Dichroism
Purified tetrameric Vip3Ag4 protein at 0.25 mg/m was desalted using a PD10 column
(GE Healthcare) and analysed using a ChirascanTM CD spectrometer (Applied Photophysics,
Leatherhead, UK) at wavelengths between 400–180 nm at 0.5 nm intervals, compared to a sample of its
original buffer (20 mM TrisHCl, pH 8.0, 300 mM NaCl) desalted in the same way, as a blank. Data were
analysed using the Dichroweb server [31].
4.5. SEC-MALLS
A size exclusion chromatography—multi angle laser light scattering (SEC-MALLS) experiment
was performed using a Superdex 200 10/300 Increase column (GE Healthcare) and an AktaPure 25
System (GE Healthcare). The Vip3Ag4 protein sample (100 µL), at a concentration of 1.0 mg/mL,
was loaded onto the gel filtration column and eluted with one column volume (24 mL) of 20 mM
TrisHCl, 300 mM NaCl buffer, pH 8.0 at a flow rate of 0.7 mL/min. The eluting protein was monitored
using a DAWN HELEOS-II 18-angle light scattering detector (Wyatt Technologies, Santa Barbara,
CA, USA) equipped with a WyattQELS dynamic light scattering module, a U9-M UV/Vis detector
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(GE Healthcare), and an Optilab T-rEX refractive index monitor (Wyatt Technologies). Data were
analysed by using Astra (Wyatt Technologies) using the default refractive index increment value of
0.185 mL/g.
4.6. Analytical Ultracentrifugation
Sedimentation velocity (SV) experiments were conducted on a Beckman ProteomeLab XL-I
analytical ultracentrifuge using an An-60 Ti rotor at 20 ◦C. Protein concentrations of 1.0, 0.5 and
0.25 mg/mL, in 20 mM Tris, 300 mM NaCl buffer, pH 8.0, were centrifuged at 20,000 rpm. Absorbance
data, at 280 nm, and interference data were collected. Data were analysed using the program SEDFIT,
fitting to the c(s) model. The density and viscosity of the buffer were measured using a DMA 5000 M
densitometer (Anton-Paar, St Albans, UK) equipped with a Lovis 200 ME viscometer. The protein partial
specific volume was calculated using SEDNTERP to allow for the calculation of molecular weight.
4.7. Transmission Electron Microscopy and Single Particle Analysis
Protein samples (100 µg/mL in Tris-HCl pH 8.0, 300 mM NaCl) were adsorbed on to carbon-coated
400 mesh copper grids and negatively stained with 2% (w/v) uranyl acetate. Transmission electron
microscopy (TEM) images were recorded in the Cardiff University high-resolution TEM facility, using
a Jeol JEM-2100 LaB6 transmission electron microscope operating at 200 kV, equipped with a 2 k Gatan
Ultrascan camera, at a specimen level increment of 2.47 Å/pixel. EMAN 2 software [32] was used
to process 3492 manually selected particles in 128 × 128 pixel boxes. The final model was generated
using four-fold symmetry from a total of 14 iterations of refinement, and Fourier shell correlation (FSC)
analysis of structures generated from even-and odd-numbered particles indicated a resolution of ~33 Å
(FSC = 0.5 criterion).
For gold labelling, purified Vip3Ag4 was incubated for 1 min at room temperature with
a 10:1 molar excess of 1.8 nm diameter nickel-nitrilotriacetic acid (Ni-NTA)-Nanogold particles
(Nanoprobes, Yaphank, NY, USA). Samples were adsorbed onto grids and washed with Nanogold
suspension to prevent unbinding of the protein-associated gold particles. After TEM and image
processing, 6286 gold-labeled Vip3Ag4 particles (in 128 × 128 pixel boxes) were automatically selected.
Three-dimensional structures were generated using the refined non-labelled Vip3Ag4 structure as
a starting model with eight rounds of iterative refinement.
For analysis of the trypsin-treated Vip3Ag4, samples were processed as for untreated protein
(above). Following the selection of 3543 particles, EMAN2 was used to construct a new model (without
reference to the model for unprocessed protein).
Supplementary Materials: The following are available online at www.mdpi.com/link, Figure S1: Sequence
of the Vip3Ag4 protein. Bold letters represent the sequence added to the N-terminus from the expression
construct and including the His-tag. Trypsin cut sites are shown as // above the two amino acids separated
by the cleavage. Numbering is given for the full-length, naturally-occurring Vip3Ag4 sequence, Figure S2: CD
analysis of Vip3Ag4. The trace for the 0.25 mg/ml Vip3Ag4 sample is shown between 185 and 240 nm. The
green curve represents the experimental data, the blue curve the data generated from the reference set, and
the pink lines show the difference between the experimental data and the reference data, Figure S3: Vip3Ag4
FSC curve. The curve for the 14th iteration of the EMAN model is shown and indicates a resolution of ~33 Å,
Figure S4: Vip3Ag4 nanogold TEM 2D class averages. (a) 2D-class averages for Vip3Ag4 gold-labelled particles.
(b) reprojections from the final 3D model, Figure S5: (a) Class averages (left) and 2D-reprojections (right) from the
3D model of trypsin-treated Vip3Ag4. (b) Fourier shell correlation (FSC) of 3D-structures derived from even- and
odd-numbered particles indicating a resolution (FSC 0.5 criterion) of approximately 26Å, Figure S6: (a) 3 views
of 3D-structure of trypsin-treated Vip3Ag4. A small region of disconnected density (likely to have resulted
from some mis-classification of particles in 3D-reconstruction) is indicated with an arrow. (b) Comparison of
trypsin-treated (cyan) and native Vip3Ag4 (green) single particle-derived structures, Table S1: Molar mass and
hydrodynamic analysis of Vip3Ag4 determined by SEC-MALLS. Table S2: Best-fit parameters obtained from AUC
SV data analysis.
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